Aveanna Healthcare operates home health and pediatric care, delivering skilled nursing, therapy and private-duty services to medically complex children and adults, largely funded by Medicaid. The moat is less a brand than a licensed footprint and clinician network that takes years to replicate in a labor-constrained field, and that scale is what keeps 13.7% revenue growth and a 12.6% operating margin possible at a 10.0 trailing P/E. The growth driver to watch is the shift of care out of hospitals and institutions into the home, which lifts demand for exactly this kind of service. At a 13.3 forward P/E against a trailing 10.0, the market is pricing in some earnings compression, which makes the next few quarters of margin and reimbursement commentary the number to check before going further.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 20 Oct 2026, 15:04 CEST | Rating | Fairly valued | first publication | $12.44 |
| 20 Oct 2026, 15:04 CEST | Fair value | $13.80 | $16.46 | $12.44 |
| 11 Oct 2026, 00:00 CEST | ACCE price target | $13.00 | first publication | $12.25 |
| 11 Oct 2026, 00:00 CEST | Fair value | $16.46 | $9.02 | $12.25 |
| 7 Oct 2026, 00:00 CEST | Fair value | $9.02 | $9.15 | $12.37 |
| 27 Sept 2026, 00:00 CEST | Fair value | $9.15 | $9.30 | $12.41 |
| 19 Sept 2026, 00:00 CEST | Fair value | $9.30 | $9.50 | $13.97 |
| 16 Sept 2026, 00:00 CEST | Fair value | $9.50 | $9.41 | $14.38 |
| 14 Sept 2026, 00:00 CEST | Fair value | $9.41 | $9.67 | $14.08 |
| 20 Aug 2026, 00:00 CEST | Fair value | $9.67 | $11.37 | $12.75 |
Answered from Aveanna Healthcare Holdings Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings Inc. Common Stock | $13.38 | $14 | 3% below | 10.6x | 198.6% | 60 | 77 |
| ACHC Acadia Healthcare Company Inc. Common Stock | $31.88 | - | - | - | -41.4% | 43 | 48 |
| MEDANTA.NS Global Health Limited | ₹1198.20 | - | - | 57.9x | - | 81 | 49 |
| GRDN Guardian Pharmacy Services Inc. Class A Common Stock | $39.59 | $23 | 76% above | 38.3x | 30.4% | 67 | 61 |
| NH.NS Narayana Hrudayalaya Limited | ₹1693.20 | - | - | 40.7x | - | 59 | 52 |
| BKD Brookdale Senior Living Inc. Common Stock | $10.19 | - | - | - | -349.6% | 26 | 25 |
| MD Pediatrix Medical Group Inc. Common Stock | $29.55 | $23 | 26% above | 13.3x | 20.4% | 69 | 74 |
Where AVAH ranks against its sector peers on each metric.